These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27133760)

  • 1. Apparent diffusion coefficient (ADC) change on repeated diffusion-weighted magnetic resonance imaging during radiochemotherapy for non-small cell lung cancer: A pilot study.
    Weiss E; Ford JC; Olsen KM; Karki K; Saraiya S; Groves R; Hugo GD
    Lung Cancer; 2016 Jun; 96():113-9. PubMed ID: 27133760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy.
    Ohno Y; Koyama H; Yoshikawa T; Matsumoto K; Aoyama N; Onishi Y; Sugimura K
    AJR Am J Roentgenol; 2012 Jan; 198(1):75-82. PubMed ID: 22194481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of optimal b-value sets for obtaining apparent diffusion coefficient free from perfusion in non-small cell lung cancer.
    Karki K; Hugo GD; Ford JC; Olsen KM; Saraiya S; Groves R; Weiss E
    Phys Med Biol; 2015 Oct; 60(20):7877-91. PubMed ID: 26406921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in Apparent Diffusion Coefficient Is Associated With Local Failure After Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: A Prospective Clinical Trial.
    Sampath S; Rahmanuddin S; Sahoo P; Frankel P; Boswell S; Wong J; Rotter A; Rockne R; Wong J; Park JM
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):659-663. PubMed ID: 31271822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of diffusion-weighted magnetic resonance imaging in patients with superior sulcus tumors receiving induction chemoradiation therapy.
    Torii I; Tateishi U; Terauchi T; Inoue T
    Jpn J Clin Oncol; 2016 Mar; 46(3):264-9. PubMed ID: 26848076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC.
    Jagoda P; Fleckenstein J; Sonnhoff M; Schneider G; Ruebe C; Buecker A; Stroeder J
    Cancer Imaging; 2021 Jan; 21(1):15. PubMed ID: 33478592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.
    Lambrecht M; Vandecaveye V; De Keyzer F; Roels S; Penninckx F; Van Cutsem E; Filip C; Haustermans K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):863-70. PubMed ID: 21398048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of treatment response after lung stereotactic body radiotherapy using diffusion weighted magnetic resonance imaging and positron emission tomography: A pilot study.
    Shintani T; Matsuo Y; Iizuka Y; Mitsuyoshi T; Umeoka S; Nakamoto Y; Mizowaki T; Togashi K; Hiraoka M
    Eur J Radiol; 2017 Jul; 92():58-63. PubMed ID: 28624021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of diffusion-weighted (DW) MRI with background signal suppression (MR-DWIBS) in diagnosis of mediastinal lymph node metastasis of nonsmall-cell lung cancer (NSCLC).
    Xu L; Tian J; Liu Y; Li C
    J Magn Reson Imaging; 2014 Jul; 40(1):200-5. PubMed ID: 24923480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of clinical outcome after stereotactic body radiotherapy for non-small cell lung cancer using diffusion-weighted MRI and (18)F-FDG PET.
    Iizuka Y; Matsuo Y; Umeoka S; Nakamoto Y; Ueki N; Mizowaki T; Togashi K; Hiraoka M
    Eur J Radiol; 2014 Nov; 83(11):2087-92. PubMed ID: 25174774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-small cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging.
    Yabuuchi H; Hatakenaka M; Takayama K; Matsuo Y; Sunami S; Kamitani T; Jinnouchi M; Sakai S; Nakanishi Y; Honda H
    Radiology; 2011 Nov; 261(2):598-604. PubMed ID: 21852569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
    Heusch P; Köhler J; Wittsack HJ; Heusner TA; Buchbender C; Poeppel TD; Nensa F; Wetter A; Gauler T; Hartung V; Lanzman RS
    Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted imaging in evaluating the efficacy of concurrent chemoradiotherapy in the treatment of non-small cell lung cancer.
    Xu HD; Zhang YQ; Shen WY; Mao ZC
    Tumori; 2018 Jun; 104(3):188-195. PubMed ID: 28362059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
    Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
    J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT.
    Ohno Y; Koyama H; Yoshikawa T; Nishio M; Aoyama N; Onishi Y; Takenaka D; Matsumoto S; Maniwa Y; Nishio W; Nishimura Y; Itoh T; Sugimura K
    Radiology; 2011 Nov; 261(2):605-15. PubMed ID: 21926377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma.
    Chen Y; Liu X; Zheng D; Xu L; Hong L; Xu Y; Pan J
    Magn Reson Imaging; 2014 Jul; 32(6):630-7. PubMed ID: 24703576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of diffusion-weighted MRI to evaluate the response to radiochemotherapy for cervical cancer.
    Kuang F; Yan Z; Wang J; Rao Z
    Magn Reson Imaging; 2014 May; 32(4):342-9. PubMed ID: 24512795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
    Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion weighted MRI and 18F-FDG PET/CT in non-small cell lung cancer (NSCLC): does the apparent diffusion coefficient (ADC) correlate with tracer uptake (SUV)?
    Regier M; Derlin T; Schwarz D; Laqmani A; Henes FO; Groth M; Buhk JH; Kooijman H; Adam G
    Eur J Radiol; 2012 Oct; 81(10):2913-8. PubMed ID: 22197090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion weighted MRI and apparent diffusion coefficient as a prognostic biomarker in evaluating chemotherapy-antiangiogenic treated stage IV non-small cell lung cancer: A prospective, single-arm, open-label, clinical trial (BevMar).
    Grundberg O; Skribek M; Swerkersson S; Skorpil M; Kölbeck K; Grozman V; Nyren S; Tsakonas G
    Eur J Radiol; 2024 Aug; 177():111557. PubMed ID: 38954912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.